Sit Investment Associates Inc. Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Sit Investment Associates Inc. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 62,896 shares of the healthcare conglomerate's stock after selling 7,563 shares during the quarter. UnitedHealth Group makes up about 0.7% of Sit Investment Associates Inc.'s portfolio, making the stock its 27th biggest position. Sit Investment Associates Inc.'s holdings in UnitedHealth Group were worth $31,817,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $25,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $32,000. Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $40,000. Finally, DecisionPoint Financial LLC raised its stake in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after buying an additional 62 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $14.09 on Wednesday, hitting $567.17. The company had a trading volume of 4,595,211 shares, compared to its average volume of 4,299,407. The company has a 50-day moving average price of $509.40 and a 200-day moving average price of $541.42. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $518.80 billion, a P/E ratio of 36.60, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm earned $5.83 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.48%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on UNH shares. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. KeyCorp reaffirmed an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. Twenty-one analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Buy" and an average target price of $630.35.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.